Skip to main
  1. Stocks
  2. Absci Corp
  3. Forecast
ABSI

Absci Corp (ABSI) Stock Forecast & Price Target

Absci Corp (ABSI) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Absci is supported by a compelling clinical and platform-driven thesis, with ABS-201 offering a differentiated anti-prolactin receptor mechanism that may produce durable hair regrowth through sustained receptor occupancy and follicular biology rather than simple cosmetic thickening. The company’s outlook is reinforced by encouraging early safety and PK data, no serious adverse events or dose-limiting toxicities, and a strong balance sheet with $173.7M in cash, cash equivalents, and marketable securities that provides runway into 2H28. Longer term, the opportunity extends beyond pattern hair loss into endometriosis, while successful validation of ABS-201 could also strengthen confidence in Absci’s AI-enabled drug discovery platform and its ability to generate proprietary, high-quality therapeutic candidates.

Bears say

Absci is a development-stage biotech with early programs and no guarantee of clinical success, while ABS-201 and other candidates face material delays from trial execution, regulatory review, competitive pressure, and reliance on third-party CDMOs. The company had $173.7M of cash, cash equivalents, and marketable securities at the end of 3Q 2026, but management only expects funding into 2H 2028 and the business is not expected to be profitable on a continuing basis until 2035. That long cash burn runway, plus the likelihood of additional capital raises and potential dilution before commercialization, makes the risk-reward profile unfavorable despite the promise of its AI-driven platform.

Absci Corp (ABSI) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Absci Corp and is not a guaranteed prediction by Public.com or investment advice.

Absci Corp (ABSI) Analyst Forecast & Price Prediction

Get the latest Absci Corp (ABSI) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Absci Corp (ABSI)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Absci Corp (ABSI) Forecast

Analysts have given Absci Corp (ABSI) a Strong Buy based on their latest research and market trends.

According to 9 analysts, Absci Corp (ABSI) has a Strong Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Absci Corp (ABSI)


Absci Corp (ABSI) Analyst Forecast & Price Prediction

Get the latest Absci Corp (ABSI) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Absci Corp (ABSI)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ABSI stock data and trends